Open-access synthetic spike-in mRNA-seq data for cancer gene fusions

BMC Genomics

Volumn 15, Issue 1, 2014, Pages

  Tembe, Waibhav D ^a   Pond, Stephanie J K ^b   Legendre, Christophe ^a   Chuang, Han Yu ^b   Liang, Winnie S ^a   Kim, Nancy E ^b   Montel, Valerie ^b   Wong, Shukmei ^a   McDaniel, Timothy K ^b   Craig, David W ^a   Carpten, John D ^a  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^b ILLUMINA INC   (United States)

Author keywords

Cancer genomics; Gene fusions; RNA seq

Indexed keywords

MESSENGER RNA; RNA BINDING PROTEIN EWS; TRANSCRIPTION FACTOR ER81;

ARTICLE; BIOINFORMATICS; CANCER GENETICS; COLONY FORMATION; DNA BASE COMPOSITION; GENE CONSTRUCT; GENE FUSION; GENE SEQUENCE; GENETIC ALGORITHM; GENETIC DISTANCE; NEXT GENERATION SEQUENCING; ONCOGENE; RNA SEQUENCE; SEQUENCE ALIGNMENT; TUMOR GENE; CARCINOGENESIS; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; METABOLISM; POLYADENYLATION; PROCEDURES; SEQUENCE ANALYSIS; TUMOR CELL LINE;

CARCINOGENESIS; CELL LINE, TUMOR; GENE FUSION; GENES, NEOPLASM; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; POLYADENYLATION; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA;

EID: 84910070971     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-824     Document Type: Article

References (18)

1. Villanueva MT. Genetics: gene fusion power. Nat Rev Clin Oncol 2012, 9:188.
2. Goldman JM, Melo JV. Chronic myeloid leukemia-advances in biology and new approaches to treatment. N Engl J Med 2003, 349:1451-1464. 10.1056/NEJMra020777, 14534339.
3. Saglio G, Morotti A, Mattioli G, Messa E, Giugliano E, Volpe G, Rege-Cambrin G, Cilloni D. Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia. Ann N Y Acad Sci 2004, 1028:423-431. 10.1196/annals.1322.050, 15650267.
4. Kakizuka A, Miller W, Umesono K, Warrel R, Franekl S, Murty V, Dmitrovsky E, Evans R. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991, 66:663-674. 10.1016/0092-8674(91)90112-C, 1652368.
5. Huang ME, Ye YC, Chen SR, Cai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988, 72:567-572.
6. Castaigne S, Chomienne C, Daniel M, Ballerini P, Berger R, Fenaux P, Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia: I. Clinical results. Blood 1990, 76:1704-1709.
7. Gerber DE, Minna JD. ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time. Cancer Cell 2010, 18:548-551. 10.1016/j.ccr.2010.11.033, 3110762, 21156280.
8. Ou SH, Bazhenova L, Camidge DR, Solomon BJ, Herman J, Kain T, Bang YJ, Kwak EL, Shaw AT, Salgia R, Maki RG, Clark JW, Wilner KD, Iafrate AJ. Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer. J Thorac Oncol 2010, 5:2044-2046. 10.1097/JTO.0b013e318200f9ff, 21102269.
9. Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, Maki RG, Ou SH, Dezube BJ, Jänne PA, Costa DB, Varella-Garcia M, Kim WH, Lynch TJ, Fidias P, Stubbs H, Engelman JA, Sequist LV, Tan W, Gandhi L, Mino-Kenudson M, Wei GC, Shreeve SM, Ratain MJ, Settleman J, Christensen JG, Haber DA, Wilner K, Salgia R, Shapiro GI, Clark JW, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010, 363:1693-1703. 10.1056/NEJMoa1006448, 3014291, 20979469.
10. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin ML, Ordóñez GR, Bignell GR, Ye K, Alipaz J, Bauer MJ, Beare D, Butler A, Carter RJ, Chen L, Cox AJ, Edkins S, Kokko-Gonzales PI, Gormley NA, Grocock RJ, Haudenschild CD, Hims MM, James T, Jia M, Kingsbury Z, Leroy C, Marshall J, Menzies A, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010, 463:191-196. 10.1038/nature08658, 3145108, 20016485.
11. Iyer MK, Chinnaiyan AM, Maher CA. ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics 2011, 27:2903-2904. 10.1093/bioinformatics/btr467, 3187648, 21840877.
12. Kim D, Salzberg SL. TopHat-fusion: an algorithm for discovery of novel fusion transcripts. Genome Biol 2011, 12:R72. 10.1186/gb-2011-12-8-r72, 3245612, 21835007.
13. Asmann YW, Hossain A, Necela BM, Middha S, Kalari KR, Sun Z, Chai HS, Williamson DW, Radisky D, Schroth GP, Kocher JP, Perez EA, Thompson EA. A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines. Nucleic Acids Res 2011, 39:e100. 10.1093/nar/gkr362, 3159479, 21622959.
14. Carrara M, Beccuti M, Lazzarato F, Cavallo F, Cordero F, Donatelli S, Calogero RA. State-of-the-art fusion-finder algorithms sensitivity and specificity. Biomed Res Int 2013, 2013:340620. 3595110, 23555082.
15. Wang Q, Xia J, Jia P, Pao W, Zhao Z. Application of next generation sequencing to human gene fusion detection: computational tools, features and perspectives. Brief Bioinform 2013, 14:506-519. 10.1093/bib/bbs044, 3713712, 22877769.
16. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012, 9:357-359. 10.1038/nmeth.1923, 3322381, 22388286.
17. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010, 26:589-595. 10.1093/bioinformatics/btp698, 2828108, 20080505.
18. Wu TD, Nacu S. Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics 2010, 26:873-881. 10.1093/bioinformatics/btq057, 2844994, 20147302.